Ocular Hypertension

"Ocular Hypertension" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.

Descriptor ID	D009798
MeSH Number(s)	C11.525
Concept/Terms	Ocular Hypertension Ocular Hypertension Hypertension, Ocular Hypertensions, Ocular Ocular Hypertensions Glaucoma, Suspect Glaucoma, Suspect Glaucomas, Suspect Suspect Glaucoma Suspect Glaucomas

Below are MeSH descriptors whose meaning is more general than "Ocular Hypertension".

Diseases [C]
Eye Diseases [C11]
Ocular Hypertension [C11.525]

Below are MeSH descriptors whose meaning is more specific than "Ocular Hypertension".

Ocular Hypertension
Glaucoma

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Ocular Hypertension" by people in this website by year, and whether "Ocular Hypertension" was a major or minor topic of these publications.

Bar chart showing 22 publications over 15 distinct years, with a maximum of 3 publications in 2019

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	2	2
1995	1	0	1
1996	1	1	2
1998	0	1	1
1999	2	0	2
2002	1	0	1
2003	1	0	1
2004	1	0	1
2008	1	0	1
2009	1	0	1
2012	2	0	2
2013	1	0	1
2014	2	0	2
2019	1	2	3
2021	0	1	1

Below are the most recent publications written about "Ocular Hypertension" by people in Profiles.

Fan J, Liu J, Liu J, Chen C, Koutalos Y, Crosson CE. Evidence for ceramide induced cytotoxicity in retinal ganglion cells. Exp Eye Res. 2021 10; 211:108762.

View in: PubMed
Maa AY, McCord S, Lu X, Janjua R, Howell AV, Hunt KJ, Medert CM, Giangiacomo A, Lynch MG. The Impact of OCT on Diagnostic Accuracy of the Technology-Based Eye Care Services Protocol: Part II of the Technology-Based Eye Care Services Compare Trial. Ophthalmology. 2020 04; 127(4):544-549.

View in: PubMed
Maa AY, Medert CM, Lu X, Janjua R, Howell AV, Hunt KJ, McCord S, Giangiacomo A, Lynch MG. Diagnostic Accuracy of Technology-based Eye Care Services: The Technology-based Eye Care Services Compare Trial Part I. Ophthalmology. 2020 01; 127(1):38-44.

View in: PubMed
de Linde Henriksen M, Lim C, Sharp JL. Treatment of canine postoperative ocular hypertension with combined latanoprost 0.005% and atropine 1% ophthalmic solutions. Vet Ophthalmol. 2019 Jul; 22(4):448-461.

View in: PubMed
Alsarraf O, Fan J, Dahrouj M, Chou CJ, Yates PW, Crosson CE. Acetylation preserves retinal ganglion cell structure and function in a chronic model of ocular hypertension. Invest Ophthalmol Vis Sci. 2014 Oct 30; 55(11):7486-93.

View in: PubMed
Sharif NA, Katoli P, Scott D, Li L, Kelly C, Xu S, Husain S, Toris C, Crosson C. FR-190997, a nonpeptide bradykinin B2-receptor partial agonist, is a potent and efficacious intraocular pressure lowering agent in ocular hypertensive cynomolgus monkeys. Drug Dev Res. 2014 Jun; 75(4):211-23.

View in: PubMed
Abdul Y, Akhter N, Husain S. Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Invest Ophthalmol Vis Sci. 2013 Mar 11; 54(3):1816-28.

View in: PubMed
Trivedi RH, Boden JH, Mickler C, Wilson ME. Intraocular pressure elevation during early postoperative period after secondary intraocular lens implantation in children and adolescents. J Cataract Refract Surg. 2012 Sep; 38(9):1633-6.

View in: PubMed
Husain S, Abdul Y, Crosson CE. Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Invest Ophthalmol Vis Sci. 2012 Jun 28; 53(7):4289-98.

View in: PubMed
Harrison BA, Whitlock NA, Voronkov MV, Almstead ZY, Gu KJ, Mabon R, Gardyan M, Hamman BD, Allen J, Gopinathan S, McKnight B, Crist M, Zhang Y, Liu Y, Courtney LF, Key B, Zhou J, Patel N, Yates PW, Liu Q, Wilson AG, Kimball SD, Crosson CE, Rice DS, Rawlins DB. Novel class of LIM-kinase 2 inhibitors for the treatment of ocular hypertension and associated glaucoma. J Med Chem. 2009 Nov 12; 52(21):6515-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals